Beyond Air Insider Buying Signals a Potential Rebound Amid FDA Push for NO‑Pulse 2.0
Beyond Air insider buying spikes: director Lin Yi‑Chien buys 21k shares amid FDA‑Phase III push for NO‑Pulse™ 2.0, hinting at a possible rebound despite steep price plunge.
4 minutes to read